Mass spectrometry for the study of protein glycation in disease

Mass Spectrometry Reviews

Volumn 25, Issue 5, 2006, Pages 713-723

[No Author Info available]

Author keywords

Cataract; Diabetes; Glycation; Liver cirrhosis; Mass spectrometry; Uremia

Indexed keywords

DESORPTION; DISEASES; HYDROLYSIS; LASER APPLICATIONS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PATIENT TREATMENT; TISSUE;

ADVANCED GLYCATION ENDPRODUCT (AGE); ELECTROSPRAY IONIZATION; LIVER CIRRHOSIS; STRUCTURAL ELUCIDATION;

PROTEINS;

ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER;

ARTICLE; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; MASS SPECTROMETRY; METABOLIC DISORDER; METABOLISM; METHODOLOGY;

BIOLOGICAL MARKERS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; METABOLIC DISEASES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33748302108     PISSN: 02777037     EISSN: None     Source Type: Journal    
DOI: 10.1002/mas.20089     Document Type: Article

References (61)

1. Agalou S, Ahmed N, Babaei-Jadidi R, Dawnay A, Thornalley PJ. 2005. Profound mishandling of protein glycation degradation products in uremia and dialysis. J Am Soc Nephrol 16:1471-1485.
2. ε-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 261:4889-4894.
3. Ahmed N, Thornalley PJ. 2002. Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence. Biochem J 364(Pt 1): 15-24.
4. ε-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 324:565-570.
5. Ahmed N, Thornalley PJ, Dawczynski J, Franke S, Strobel J, Stein G, Haik GM. 2003. Methylglyoxal-derived hydroimidazolone advanced glyca tion end-products of human lens proteins. Invest Ophthalmol Vis Sci 44:5287-5292.
6. Ahmed N, Thornalley PJ, Luthen R, Haussinger D, Sebekova K, Schinzel R, Voelker W, Heidland A. 2004. Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis. J Hepatol 41:913-919.
7. Ahmed N, Luthen R, Haussinger D, Sebekova K, Schinzel R, Voelker W, Heidland A, Thornalley PJ. 2005a. Increased protein glycation in cirrhosis and therapeutic strategies to prevent it. Ann N Y Acad Sci 1043:718-724.
8. Ahmed N, Babaei-Jadidi R, Howell SK, Beisswenger PJ, Thornalley PJ. 2005b. Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes. Diabetologia 48: 1590-1603.
9. Baynes JW. 2002. The Maillard hypothesis on aging: Time to focus on DNA. Ann NY Acad Sci 959:360-367.
10. Baynes JW, Thorpe SR. 2000. Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 28:1708-1716.
11. Biemel KM, Friedl DA, Lederer MO. 2002. Identification and quantification of major Maillard cross-links in human serum albumin and lens protein. Evidence for glucosepane as the dominant compound. J Biol Chem 277: 24907-24915.
12. Bucala R, Model P, Cerami A. 1984. Modification of DNA by reducing sugars: A possible mechanism for nucleic acid aging and age-related dysfunction in gene expression. Proc Natl Acad Sci USA 81:105-109.
13. ε-(carboxymethyl)lysine by reaction between lysine and products of autoxidation of ascorbate. Biochemistry 29:10964-10970.
14. Franke S, Dawczynski J, Strobel J, Niwa T, Stahl P, Stein G. 2003. Increased levels of advanced glycation end products in human cataractous lenses. J Cataract Refract Surg 29:998-1004.
15. Frye EB, Degenhardt TP, Thorpe SR, Baynes JW. 1998. Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins. J Biol Chem 273:18714-18719.
16. Hasenkopf K, Ronner B, Hiller H, Pischetsrieder M. 2002. Analysis of glycated and ascorbylated proteins by gas chromatography-mass spectrometry. J Agric Food Chem 50:5697-5703.
17. Hayase F, Nagaraj RH, Miyata S, Njoroge FG, Monnier VM. 1989. Aging of proteins: Immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo. J Biol Chem 264:3758-3764.
18. Humeny A, Kislinger T, Becker CM, Pischetsrieder M. 2002. Qualitative determination of specific protein glycation products by matrix-assisted laser desorption/ionization mass spectrometry Peptide mapping. J Agric Food Chem 50:2153-2160.
19. Ienaga K, Nakamura K, Hochi T, Nakazawa Y, Fukunaga Y, Kakita H, Nakano K. 1995. Crosslines, fluorophores in the AGE-related cross-linked proteins. Contrib Nephrol 112:42-51.
20. ω-carboxymethylarginine as a novel acid-labileadvanced glycation end product in collagen. Biochem J 347:23-27.
21. Karachalias N, Babaei-Jadidi R, Ahmed N, Thornalley PJ. 2003. Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats. Biochem Soc Trans 31:1423-1425.
22. Kislinger T, Humeny A, Pischetsrieder M. 2004. Analysis of protein glycation products by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Curr Med Chem 11:2185-2193.
23. ε-(carboxymethyl) lysine, imidazolone A, and the Amadori product in glycated lysozyme by MALDI-TOF mass spectrometry. J Agric Food Chem 51:51-57.
24. Kislinger T, Humeny A, Peich CC, Becker CM, Pischetsrieder M. 2005. Analysis of protein glycation products by MALDI-TOF/MS. Ann N Y Acad Sci 1043:249-259.
25. Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. 1976. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med 295:417-420.
26. Lapolla A, Fedele D, Aronica R, Garbeglio M, D'Alpaos M, Seraglia R, Traldi P. 1997. Evaluation of IgG glycation levels by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom 11:1342-1346.
27. Lapolla A, Fedele D, Plebani M, Garbeglio M, Seraglia R, D' Alpaos M, Arico CN, Traldi P. 1999. Direct evaluation of glycated and glyco-oxidized globins by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom 13:8-14.
28. Lapolla A, Fedele D, Garbeglio M, Martano L, Tonani R, Seraglia R, Favretto D, Fedrigo MA, Traldi P. 2000. Matrix-assisted laser desorption/ionization mass spectrometry, enzymatic digestion, and molecular modeling in the study of nonenzymatic glycation of IgG. J Am Soc Mass Spectrom 11:153-159.
29. Lapolla A, Fedele D, Martano L, Arico' NC, Garbeglio M, Traldi P, Seraglia R, Favretto D. 2001. Advanced glycation end products: A highly complex set of biologically relevant compounds detected by mass spectrometry. J Mass Spectrom 36:370-378.
30. Lapolla A, Tonani R, Fedele D, Garbeglio M, Senesi A, Seraglia R, Favretto D, Traldi P. 2002. Non-enzymatic glycation of IgG: An in vivo study. Horm Metab Res 34:260-264.
31. Lapolla A, Flamini R, Dalla Vedova A, Senesi A, Reitano R, Fedele D, Basso E, Seraglia R, Traldi P. 2003. Glyoxal and methylglyoxal levels in diabetic patients: Quantitative determination by a new GC/MS method. Clin Chem Lab Med 41:1166-1173.
32. Lapolla A, Fedele D, Reitano R, Arico NC, Seraglia R, Traldi P, Marotta E, Tonani R. 2004a. Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides. J Am Soc Mass Spectrom 15:496-509.
33. Lapolla A, Tubaro M, Reitano R, Arico NC, Ragazzi E, Seraglia R, Vogliardi S, Traldi P, Fedele D. 2004b. The complexity of non-enzymatic glycation product sets of human globins. Diabetologia 47:1712-1715.
34. Lapolla A, Tubaro M, Fedele D, Reitano R, Arico NC, Ragazzi E, Seraglia R, Vogliardi S, Traldi P. 2005. A matrix-assisted laser desorption/ionization mass spectrometry study of the non-enzymatic glycation products of human globins in diabetes. Rapid Commun Mass Spectrom 19:162-168.
35. 2-Carboxyethyl-2′-deoxyguanosine, a DNA glycation marker, in kidneys and aortas of diabetic and uremic patients. Kidney Int 69:388-392.
36. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, Friedman EA, Cerami A, Vlassara H. 1991. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325:836-842.
37. Marotta E, Lapolla A, Fedele D, Senesi A, Reitano R, Witt M, Seraglia R, Traldi P. 2003. Accurate mass measurements by Fourier transform mass spectrometry in the study of advanced glycation end products/peptides. J Mass Spectrom 38:196-205.
38. Mironova R, Niwa T, Hayashi H, Dimitrova R, Ivanov 1.2001. Evidence for non-enzymatic glycosylation in Escherichia coli. Mol Microbiol 39: 1061-1068.
39. Mironova R, Niwa T, Dimitrova R, Boyanova M, Ivanov I. 2003. Glycation and post-translational processing of human interferon-γ expressed in Escherichia coli. J Biol Chem 278:51068-51074.
40. Nagai R, Hayashi CM, Xia L, Takeya M, Horiuchi S. 2002. Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins. J Biol Chem 277:48905-48912.
41. Nakamura K, Nakazawa Y, Ienaga K. 1997. Acid-stable fluorescent advanced glycation end products: Vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose. Biochem Biophys Res Commun 232:227-230.
42. Nakamura S, Niwa T. 2005. Pyridoxal phosphate and hepatocyte growth factor prevent dialysate-induced peritoneal damage. J Am Soc Nephrol 16:144-150.
43. Niwa T. 1997c. Mass spectrometry in the search for uremic toxins. Mass Spectrom Rev 16:307-332.
44. Niwa T. 1999. 3-Deoxyglucosone: Metabolism, analysis, biological activity and clinical implication. J Chromatogr 731:23-36.
45. Niwa T, Tsukushi S. 2001. 3-deoxyglucosone and AGEs in uremic complications: Inactivation of glutathione peroxidase by 3-deoxyglucosone. Kidney Int 59(Suppl 78):S37-S41.
46. Niwa T, Takeda N, Yoshizumi H, Tatematsu A, Ohara M, Tomiyama S, Niimura K. 1993. Presence of 3 deoxyglucosone, a potent protein crosslinking intermediate of Maillard reaction, in diabetic serum. Biochem Biophys Res Commun 196:837-843.
47. 2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum. Kidney Int 49: 861-867.
48. Niwa T, Katsuzaki T, Miyazaki S, Miyazaki T, Ishizaki Y, Hayase F, Tatemichi N, Takei Y. 1997a. Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients. J Clin Invest 99:1272-1280.
49. Niwa T, Katsuzaki T, Ishizaki Y, Hayase F, Miyazaki T, Uematsu T, Tatemichi N, Takei Y. 1997b. Imidazolone, a novel advanced glycation end product, is present at high levels in kidneys of rats with streptozotocin- induced diabetes. FEBS Lett 407:297-302.
50. Odani H, Shinzato T, Usami J, Matsumoto Y, Brinkmann Frye E, Baynes JW, Maeda K. 1998. Imidazolium crosslinks derived from reaction of lysine with glyoxal and methylglyoxal are increased in serum proteins of uremic patients: Evidence for increased oxidative stress in uremia. FEBS Lett 427:381-385.
51. Oya T, Kumon H, Kobayashi H, Akiba M, Hosokawa T, Kakimoto N, Nakamura K, Morimitsu Y, Osawa T. 1998. A novel biomarker for hyperglycemia, MRX isolated from hydrolysate of glycated proteins. Biochem Biophys Res Commun 246:267-271.
52. Papanastasiou P, Grass L, Rodela H, Patrikarea A, Oreopoulos D, Diamandis EP. 1994. Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. Kidney Int 46:216-222.
53. 2-carboxyethyl-2′- deoxyguanosine. Chem Res Toxicol 17:1385-1390.
54. Sell DR, Monnier VM. 1989. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem 264:21597-21602.
55. Shipanova IN, Glomb MA, Nagaraj RH. 1997. Protein modification by methylglyoxal: Chemical nature and synthetic mechanism of a major fluorescent adduct. Arch Biochem Biophys 344:29-36.
56. Skovsted IC, Christensen M, Breinholt J, Mortensen SB. 1998. Characterisation of a novel AGE-compound derived from lysine and 3-deoxyglucosone. Cell Mol Biol 44:1159-1163.
57. ε-(carboxyethyl) lysine in human plasma protein by stable-isotope-dilution tandem mass spectrometry. Clin Chem 50:1222-1228.
58. Thornalley PJ, Langborg A, Minhas HS. 1999. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 344:109-116.
59. Thornalley PJ, Argirova M, Ahmed N, Mann VM, Argirov O, Dawnay A. 2000. Mass spectrometric monitoring of albumin in uremia. Kidney Int 58:2228-2234.
60. Thornalley PJ, Battah S, Ahmed N, Karachalias N, Agalou S, Babaei-Jadidi R, Dawnay A. 2003. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 375:581-592.
61. Tsukushi S, Katsuzaki T, Aoyama I, Takayama F, Miyazaki T, Shimokata K, Niwa T. 1999. Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: Role of the polyol pathway. Kidney Int 55: 1970-1976.